BACKGROUND: Mutations in the RMND1 (Required for Meiotic Nuclear Division protein 1) gene have recently been linked to infantile onset mitochondrial disease characterised by multiple mitochondrial respiratory chain defects. METHODS: We summarised the clinical, biochemical and molecular genetic investigation of an international cohort of affected individuals with RMND1 mutations. In addition, we reviewed all the previously published cases to determine the genotype-phenotype correlates and performed survival analysis to identify prognostic factors. RESULTS: We identified 14 new cases from 11 pedigrees that harbour recessive RMND1 mutations, including 6 novel variants: c.533C>A, p.(Thr178Lys); c.565C>T, p.(Gln189*); c.631G>A, p.(Val211Met); c.1303C>T, p.(Leu435Phe); c.830+1G>A and c.1317+1G>T. Together with all previously published cases (n=32), we show that congenital sensorineural deafness, hypotonia, developmental delay and lactic acidaemia are common clinical manifestations with disease onset under 2 years. Renal involvement is more prevalent than seizures (66% vs 44%). In addition, median survival time was longer in patients with renal involvement compared with those without renal disease (6 years vs 8 months, p=0.009). The neurological phenotype also appears milder in patients with renal involvement. CONCLUSIONS: The clinical phenotypes and prognosis associated with RMND1 mutations are more heterogeneous than that were initially described. Regular monitoring of kidney function is imperative in the clinical practice in light of nephropathy being present in over 60% of cases. Furthermore, renal replacement therapy should be considered particularly in those patients with mild neurological manifestation as shown in our study that four recipients of kidney transplant demonstrate good clinical outcome to date.

1st Faculty of Medicine Institute for Inherited Metabolic Disorders Charles University Prague Prague Czech Republic

Clinical Genetics Unit West Midlands Regional Genetics Service Birmingham Women's NHS Foundation Trust Birmingham UK

Department of Clinical Genetics Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Department of Clinical Genetics Temple Street Children's University Hospital Dublin Ireland

Department of Clinical Inherited Metabolic Disorders Birmingham Children's Hospital NHS Foundation Trust Birmingham UK

Department of Genetic Medicine Central Manchester University Hospitals NHS Foundation Trust St Mary's Hospital Manchester UK

Department of Genetics Harvard Medical School Boston Massachusetts USA

Department of Medical and Molecular Genetics Centre for Rare Diseases and Personalised Medicine School of Clinical and Experimental Medicine University of Birmingham Birmingham UK

Department of Medicine and the Howard Hughes Medical Institute Brigham and Women's Hospital Boston Massachusetts USA

Department of Metabolic Medicine Great Ormond Street Hospital NHS Foundation Trust London UK

Department of Neurology George Washington University Medical School Children's National Health System Washington DC USA

Department of Paediatric Medicine Leeds General Infirmary Leeds UK

Department of Paediatric Medicine The Royal Belfast Hospital for Sick Children Belfast UK

Department of Paediatric Neurology Central Manchester University Hospitals NHS Foundation Trust Manchester UK

Department of Pediatrics Aga Khan University Karachi Pakistan

Department of Pediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic

Division of Child Neurology Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA

Division of Metabolism Children Research Hospital Bambino Gesù Rome Italy

Faculty of Health and Life Sciences Oxford Brookes University Oxford UK

Institute for Molecular Bioscience University of Queensland St Lucia Queensland Australia

Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic

Leicester Children's Hospital Leicester Royal Infirmary Leicester UK

National Centre for Inherited Metabolic Disorders Temple Street Children's University Hospital Dublin Ireland

Neuromuscular and Neurodegenerative Disease Unit Children Research Hospital Bambino Gesù Rome Italy

Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust The Churchill Hospital Oxford UK

Pediatric Nephrology Unit Hospital Universitario Reina Sofia Cordoba Spain

Wellcome Trust Centre for Mitochondrial Research Institute of Neuroscience Newcastle University Newcastle upon Tyne UK

Zobrazit více v PubMed

Mayr JA, Haack TB, Freisinger P, Karall D, Makowski C, Koch J, Feichtinger RG, Zimmermann FA, Rolinski B, Ahting U, Meitinger T, Prokisch H, Sperl W. Spectrum of combined respiratory chain defects. J Inherit Metab Dis 2015;38:629–40. 10.1007/s10545-015-9831-y PubMed DOI PMC

Garcia-Diaz B, Barros MH, Sanna-Cherchi S, Emmanuele V, Akman HO, Ferreiro-Barros CC, Horvath R, Tadesse S, El Gharaby N, DiMauro S, De Vivo DC, Shokr A, Hirano M, Quinzii CM. Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. Am J Hum Genet 2012;91:729–36. 10.1016/j.ajhg.2012.08.019 PubMed DOI PMC

Janer A, Antonicka H, Lalonde E, Nishimura T, Sasarman F, Brown GK, Brown RM, Majewski J, Shoubridge EA. An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. Am J Hum Genet 2012;91:737–43. 10.1016/j.ajhg.2012.08.020 PubMed DOI PMC

Janer A, van Karnebeek CD, Sasarman F, Antonicka H, Al Ghamdi M, Shyr C, Dunbar M, Stockler-Ispiroglu S, Ross CJ, Vallance H, Dionne J, Wasserman WW, Shoubridge EA. RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multiorgan involvement. Eur J Hum Genet 2015;23:1301–7. 10.1038/ejhg.2014.293 PubMed DOI PMC

Casey JP, Crushell E, Thompson K, Twomey E, He L, Ennis S, Philip RK, Taylor RW, King MD, Lynch SA. Periventricular Calcification, Abnormal Pterins and Dry Thickened Skin: Expanding the Clinical Spectrum of RMND1? JIMD Rep 2016;26:13–19. 10.1007/8904_2015_479 PubMed DOI PMC

Ravn K, Neland M, Wibrand F, Duno M, Ostergaard E. Hearing impairment and renal failure associated with RMND1 mutations. Am J Med Genet A 2016;170A:142–7. 10.1002/ajmg.a.37399 PubMed DOI

Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 2004;14:237–45. 10.1016/j.nmd.2003.12.004 PubMed DOI

Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, He L, Smertenko T, Alston CL, Neeve VC, Best A, Yarham JW, Kirschner J, Schara U, Talim B, Topaloglu H, Baric I, Holinski-Feder E, Abicht A, Czermin B, Kleinle S, Morris AA, Vassallo G, Gorman GS, Ramesh V, Turnbull DM, Santibanez-Koref M, McFarland R, Horvath R, Chinnery PF. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA 2014;312:68–77. 10.1001/jama.2014.7184 PubMed DOI PMC

Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, Hershman SG, Gold NB, Chapman BA, Thorburn DR, Berry GT, Schmahmann JD, Borowsky ML, Mueller DM, Sims KB, Mootha VK. Targeted exome sequencing of suspected mitochondrial disorders. Neurology 2013;80:1762–70. 10.1212/WNL.0b013e3182918c40 PubMed DOI PMC

Ferreiro-Barros CC, Tengan CH, Barros MH, Palenzuela L, Kanki C, Quinzii C, Lou J, El Gharaby N, Shokr A, De Vivo DC, DiMauro S, Hirano M. Neonatal mitochondrial encephaloneuromyopathy due to a defect of mitochondrial protein synthesis. J Neurol Sci 2008;275:128–32. 10.1016/j.jns.2008.08.028 PubMed DOI PMC

Nickerson JP, Richner B, Santy K, Lequin MH, Poretti A, Filippi CG, Huisman TA. Neuroimaging of pediatric intracranial infection--part 2: TORCH, viral, fungal, and parasitic infections. J Neuroimaging 2012;22:e52–63. 10.1111/j.1552-6569.2011.00699.x PubMed DOI

Che R, Yuan Y, Huang S, Zhang A. Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol Renal Physiol 2014;306:F367–78. 10.1152/ajprenal.00571.2013 PubMed DOI

Gorman GS, Taylor RW. RRM2B-related mitochondrial disease. In: Pagon RA, Adam MP, Ardinger HH, et al., eds GeneReviews(R). Seattle, WA: University of Washington; All rights reserved. 2014.

Emmanuele V, López LC, Berardo A, Naini A, Tadesse S, Wen B, D'Agostino E, Solomon M, DiMauro S, Quinzii C, Hirano M. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol 2012;69:978–83. 10.1001/archneurol.2012.206 PubMed DOI PMC

Belostotsky R, Ben-Shalom E, Rinat C, Becker-Cohen R, Feinstein S, Zeligson S, Segel R, Elpeleg O, Nassar S, Frishberg Y. Mutations in the mitochondrial Seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet 2011;88:193–200. 10.1016/j.ajhg.2010.12.010 PubMed DOI PMC